Bevacizumab therapy for POEMS syndrome
2006; Elsevier BV; Volume: 107; Issue: 12 Linguagem: Inglês
10.1182/blood-2005-12-5045
ISSN1528-0020
AutoresOddbjørn Straume, Jann Bergheim, Peter Ernst,
Tópico(s)Coagulation, Bradykinin, Polyphosphates, and Angioedema
ResumoWe read the case report from Badros and coworkers with great interest.[1][1] A patient with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) was successfully treated with bevacizumab. Increased level of vascular-endothelial growth factor (VEGF)
Referência(s)